Literature DB >> 7909248

Mapping of Simpson-Golabi-Behmel syndrome to Xq25-q27.

J Y Xuan1, A Besner, M Ireland, R M Hughes-Benzie, A E MacKenzie.   

Abstract

Simpson-Golabi-Behmel syndrome (SGBS) is an X-linked gigantism syndrome characterized primarily by a coarse facies and somatic overgrowth which we have observed to be associated with an increased risk for embryonal tumors. Genetic linkage analysis for two SGBS kindreds in which X linked dominant inheritance was observed has been conducted for the X chromosome. The closest linkage to SGBS was observed for the Xq26 locus HPRT (Z max = 7.45, theta max = 0.00). SGBS-Xq marker recombinations map the disease locus to the DXS425-DXS1123 interval on Xq25-q27. This maps the disease locus to a region known to contain a previously characterized chromosomal translocation breakpoint found in a young girl with somatic overgrowth. This observation may have implications for the cloning of the SGBS gene.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7909248     DOI: 10.1093/hmg/3.1.133

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  5 in total

1.  Mapping of the Simpson-Golabi-Behmel overgrowth syndrome gene (GPC3) to chromosome X in human and rat by fluorescence in situ hybridization.

Authors:  T Shen; G Sonoda; J Hamid; M Li; J Filmus; R N Buick; J R Testa
Journal:  Mamm Genome       Date:  1997-01       Impact factor: 2.957

2.  Mapping of a new SGBS locus to chromosome Xp22 in a family with a severe form of Simpson-Golabi-Behmel syndrome.

Authors:  L M Brzustowicz; S Farrell; M B Khan; R Weksberg
Journal:  Am J Hum Genet       Date:  1999-09       Impact factor: 11.025

3.  A patient with Simpson-Golabi-Behmel syndrome and hepatocellular carcinoma.

Authors:  P Lapunzina; I Badia; C Galoppo; E De Matteo; P Silberman; A Tello; J Grichener; R Hughes-Benzie
Journal:  J Med Genet       Date:  1998-02       Impact factor: 6.318

4.  Molecular genetic basis of Wilms' tumour?

Authors:  T R Cole
Journal:  Br J Cancer       Date:  1995-02       Impact factor: 7.640

5.  Somatic glypican 3 (GPC3) mutations in Wilms' tumour.

Authors:  G R M White; A M Kelsey; J M Varley; J M Birch
Journal:  Br J Cancer       Date:  2002-06-17       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.